Home-based Complex Intervention for Children With Ataxia Telangiectasia
Ataxia Telangiectasia in Children, Ataxia Telangiectasia
About this trial
This is an interventional treatment trial for Ataxia Telangiectasia in Children focused on measuring ataxia telangiectasia, ataxia, children, physical therapy, physiotherapy, exercise, yoga, breathing exercise, pilot RCT, complex intervention, home-based intervention
Eligibility Criteria
Inclusion Criteria: Diagnosis of A-T confirmed clinically Aged 4-11 years Able to walk independently (with no or only intermittent support) over 10 metres and stand unaided for 1 minute Able to communicate in English either independently or with the assistance of their parent/legal guardian (where parent/guardian is able to communicate in English) or using a translator arranged by the participating family Has the ability to assent and parents/legal guardians have the ability to give consent on their child's behalf Exclusion Criteria: Those with other/additional diagnoses thought by the study team to probably compromise the intervention, e.g. with significant intellectual disability Currently undergoing cancer therapies or acutely unwell Children who are participants of another trial/intervention programme Non-UK based families
Sites / Locations
- University of PlymouthRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Early start group
Delayed start group
Participants in this group will receive a baseline monitoring period of 1 week, an active remotely supervised and monitored intervention period of 8 weeks and then an unsupervised but monitored follow up period of 4 months. They will be assessed at baseline (T0) and after one week (T1) to determine the sensitivity of the measures. They will then begin their intervention (T2) for a period of 8 weeks. At the end of the intervention phase (T3), assessment will be repeated that will also mark the beginning of a 16 weeks follow up period (T4), during this time they will have the choice to continue the exercises or stop them. At the end of the follow up period, assessment will be carried out again to measure any carry over effects.
Participants in this group will receive a baseline monitoring period of 1 week, a control period of 8 weeks, an active remotely supervised and monitored intervention period of 8 weeks and then an unsupervised but monitored follow up period of 2 months. They will be assessed at baseline (T0) and after one week (T1) to determine the sensitivity of the measures. While the early start group receives their 8-week intervention, this group will not receive any intervention during this control period. At the end of 8 weeks, an assessment will be carried out for this group as well (T2). The participants will then begin their intervention (T3) for a period of 8 weeks. At the end of the intervention phase (T4), assessment will be repeated that will mark the beginning of an 8 weeks follow up period (T5), during this time they will have the choice to continue the exercises or stop them. At the end of the follow up period (T6), assessment will be carried out again to measure any carry over effects.